PLSE

NEUTRALEarnings

Pulse Biosciences, Inc

2026-10-22

Price

$52.68

+3.62%

This is the 2026-10-22 snapshot — the signals and analysis for PLSE as of this single trading day.

View full PLSE research hub →

Score2.5Noise

Signals2/8 DNA1/13 Act · 2/4 Risk

SentimentNEUTRALScore: 8

Volume0.7xvs 20d avg

Analysis

PLSE is demonstrating High-Conviction Price Discovery as it consolidates near recent highs following a string of aggressive analyst upgrades and successful clinical trial enrollments for its nPulse system. The PERFECT_STACK and SMA_BOUNCE technical signals confirm robust institutional absorption, perfectly aligning with today's announcement of a November 5 earnings date. In the current RISK_ON (EARNINGS) regime, where tight credit spreads and a dropping VIX encourage risk-taking despite headline macro noise, PLSE's +27% relative strength highlights aggressive accumulation ahead of its next fundamental catalyst.

Fired Signals

GOLDEN CROSSPERFECT STACKSMA BOUNCEEXTENSIONDISTRIBUTION

Key Takeaways

Actionable Thesis: PLSE is a high-conviction momentum long, supported by structural clinical catalysts, recent $60 price target upgrades, and strong technical alignment.
Key Risk: With annualized volatility at 88.5% and a massive 27% one-month run, the stock is susceptible to sharp mean-reversion if broader risk appetite suddenly contracts.
What to Watch: Monitor the $43.32 line-in-the-sand for structural support and look toward the November 5 Q3 earnings call for forward guidance on commercial partnerships.

← Back to 2026-10-22 View Full PLSE History →Yahoo Finance &nearr;